These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24935370)

  • 41. Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation.
    Zanotta N; Tornesello ML; Annunziata C; Stellato G; Buonaguro FM; Comar M
    PLoS One; 2016; 11(3):e0151851. PubMed ID: 26990868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study.
    Scott ME; Shvetsov YB; Thompson PJ; Hernandez BY; Zhu X; Wilkens LR; Killeen J; Vo DD; Moscicki AB; Goodman MT
    Int J Cancer; 2013 Sep; 133(5):1187-96. PubMed ID: 23436563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human Papillomavirus Type 16 Disables the Increased Natural Killer Cells in Early Lesions of the Cervix.
    Zhang J; Jin S; Li X; Liu L; Xi L; Wang F; Zhang S
    J Immunol Res; 2019; 2019():9182979. PubMed ID: 31183395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In situ detection of SOCS and cytokine expression in the uterine cervix from HIV/HPV coinfected women.
    Nicol AF; Nuovo GJ; Wang Y; Grinsztejn B; Tristão A; Russomano F; Perez MA; Lapa e Silva JR; Fernandes AT; Gage JR; Martínez-Maza O; Bonecini-Almeida MG
    Exp Mol Pathol; 2006 Aug; 81(1):42-7. PubMed ID: 16878360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlates of IL-10 and IL-12 concentrations in cervical secretions.
    Gravitt PE; Hildesheim A; Herrero R; Schiffman M; Sherman ME; Bratti MC; Rodriguez AC; Morera LA; Cardenas F; Bowman FP; Shah KV; Crowley-Nowick PA
    J Clin Immunol; 2003 May; 23(3):175-83. PubMed ID: 12797539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arginase is involved in cervical lesions progression and severity.
    Souid M; Ghedira R; Souissi S; Bouzgarrou N; Gabbouj S; Shini-Hadhri S; Rhim MS; Boukadida A; Toumi D; Faleh R; Bouaouina N; Zakhama A; Hassen E
    Immunobiology; 2022 Mar; 227(2):152189. PubMed ID: 35220072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytokine and immunoglobulin concentrations in cervical secretions: reproducibility of the Weck-cel collection instrument and correlates of immune measures.
    Hildesheim A; McShane LM; Schiffman M; Bratti MC; Rodriguez AC; Herrero R; Morera LA; Cardenas F; Saxon L; Bowman FP; Crowley-Nowick PA
    J Immunol Methods; 1999 May; 225(1-2):131-43. PubMed ID: 10365790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered vaginal cervical microbiota diversity contributes to HPV-induced cervical cancer
    Yang Y; Zhu J; Feng R; Han M; Chen F; Hu Y
    PeerJ; 2024; 12():e17415. PubMed ID: 38881859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Collection of cervical secretions does not adversely affect Pap smears taken immediately afterward.
    Hildesheim A; Bratti MC; Edwards RP; Schiffman M; Rodriguez AC; Herrero R; Alfaro M; Morera LA; Ermatinger SV; Miller BT; Crowley-Nowick PA
    Clin Diagn Lab Immunol; 1998 Jul; 5(4):491-3. PubMed ID: 9665954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon-induced gene expression in cervical mucosa during human papillomavirus infection.
    Pierangeli A; Degener AM; Ferreri ML; Riva E; Rizzo B; Turriziani O; Luciani S; Scagnolari C; Antonelli G
    Int J Immunopathol Pharmacol; 2011; 24(1):217-23. PubMed ID: 21496405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of serum and mucosal neutralizing antibodies to human papillomavirus type 16 (HPV-16) with HPV-16 infection and cervical disease.
    Mbulawa ZZA; Williamson AL; Stewart D; Passmore JS; Denny L; Allan B; Marais DJ
    J Gen Virol; 2008 Apr; 89(Pt 4):910-914. PubMed ID: 18343831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in the concentration and correlation of cervical immune markers among HPV positive and negative perimenopausal women.
    Marks MA; Viscidi RP; Chang K; Silver M; Burke A; Howard R; Gravitt PE
    Cytokine; 2011 Dec; 56(3):798-803. PubMed ID: 22015106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of two types of sponges used to collect cervical secretions and assessment of antibody extraction protocols for recovery of neutralizing anti-human papillomavirus type 16 antibodies.
    Kemp TJ; Hildesheim A; Falk RT; Schiller JT; Lowy DR; Rodriguez AC; Pinto LA
    Clin Vaccine Immunol; 2008 Jan; 15(1):60-4. PubMed ID: 18032596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Papanicolaou smears and cervical inflammatory cytokine responses.
    Passmore JA; Morroni C; Shapiro S; Williamson AL; Hoffman M
    J Inflamm (Lond); 2007 Apr; 4():8. PubMed ID: 17456234
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diminished IFN-gamma and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3.
    Scott ME; Ma Y; Kuzmich L; Moscicki AB
    Int J Cancer; 2009 Mar; 124(6):1379-83. PubMed ID: 19089920
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of biomarker panel to predict, prevent and create treatments tailored to the persons with human papillomavirus-induced cervical precancerous lesions.
    Lazarenko LM; Nikitina OE; Nikitin EV; Demchenko OM; Kovtonyuk GV; Ganova LO; Bubnov RV; Shevchuk VO; Nastradina NM; Bila VV; Spivak MY
    EPMA J; 2014 Jan; 5(1):1. PubMed ID: 24386936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The correlation of HPV16 and HPV18 with local vaginal immunity after the treatment of cervical intraepithelial neoplasia.
    Mu L; Miao JR; Song JH
    Transl Cancer Res; 2020 Jul; 9(7):4212-4223. PubMed ID: 35117789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between interleukin-2, interleukin-10, secretory immunoglobulin A and immunoglobulin G expression in vaginal fluid and human papilloma virus outcome in patients with cervical lesions.
    Meng JW; Song JH
    Oncol Lett; 2019 Nov; 18(5):5543-5548. PubMed ID: 31612062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Defining the validity of classical and non-classical cellular changes indicative of low-grade squamous intraepithelial lesion encompassing human papillomavirus infection in relation to human papillomavirus deoxyribonucleic acid testing.
    Kashyap V; Hedau S; Bhambhani S
    J Cytol; 2011 Oct; 28(4):159-64. PubMed ID: 22090688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cryotherapy of Erosion of Cervix and Low Grade Squamous Intraepithelial Lesion.
    Jahic M
    Mater Sociomed; 2018 Dec; 30(4):294-296. PubMed ID: 30936796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.